Dr. Joshua Boger left his job as a scientist at Merck in 1989 with the dream of founding a new kind of drug company, and the resulting development of Vertex Pharmaceuticals (NASDAQ: VRTX) inspired the New York Times best-seller The Billion-Dollar Molecule and launched one of Boston’s and the nation’s fastest growing public companies.
What people don’t know about Vertex is that the company’s Strategy Map and top management’s Balanced Scorecard has systematically prioritized the “Health Value” of “Transforming Lives” to help power and organize its dramatic global growth even as it brought a rationalization of the drug discovery process to humankind’s battle against disease. Vertex’s success in designing drugs that treat monumentally complex illnesses is a testament to the transformative power of socially-purposed business.
At the Alliance’s Fall CEO Summit, Dr. Boger will share for the first time an outline of the Strategy Map and Balanced Scorecard that Vertex has used to ensure that the company’s health mission helps organize and animate its business. He will also discuss his work as Chair of Board at Wesleyan, bringing a Balanced Scorecard approach to non-profit management, as well as his next-generation drug discovery company Alkeus Pharmaceuticals. Support The Alliance for Business Leadership and join Joshua, former ZipCar CEO, Scott Griffith, Hollister Staffing CEO Kip Hollister, Harvard Business School Professor Rebecca Henderson and many others for unforgettable discussions and insights into Business Innovators & Shared Value Creation on October 23rd at the Harvard Club in Boston’s Back Bay 8:30am to 2pm.